Tech Company Financing Transactions
Hygeia Therapeutics Funding Round
Hygeia Therapeutics secured a $1 million Series A funding round on 4/19/2010. Investors included private investors.
Transaction Overview
Company Name
Announced On
4/19/2010
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Series A
Investors
Proceeds Purpose
The funding will go to testing its topical synthetic estrogen drug designed to treat age-related skin thinning, and will fuel the development of a topical anti-androgen drug.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8 Canterbury Ln.
Holden, MA 01520
USA
Holden, MA 01520
USA
Phone
Website
Email Address
Overview
Hygeia Therapeutics acquires and develops biodegradable hormone receptor modulators for topical indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yael Schwartz
Chief Financial Officer
Walter Greenblatt
Chief Medical Officer
David Shepro
Chief Scientific Officer
Craig Abolin
Co-Founder
Tom Jerussi
VP - Bus. Development
Sanjeev Popli
Browse more venture capital transactions:
Prev: 4/19/2010: Synerchip venture capital transaction
Next: 4/19/2010: Fusion-io venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs